Chicago Capital Management’s Esperion Therapeutics ESPR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-830,935
Closed -$2.61M – 31
2026
Q2
$2.61M Buy
+830,935
New +$2.32M 2.32% 19

Other funds holding ESPR

Chicago Capital Management's ESPR Position: Q3 2026 in Review

Chicago Capital Management sold out of Esperion Therapeutics (ESPR) in Q3 2026, closing a stake of 830,935 shares — an estimated $2.61M sold.

Chicago Capital Management first reported a position in ESPR in Q2 2026 and held it in 1 quarter. The position peaked at $2.61M in Q2 2026. 2 funds tracked by Wall St. Rank hold ESPR as of Q3 2026.

  • Chicago Capital Management reported no remaining Esperion Therapeutics position as of Q3 2026 after selling out during the quarter.
  • Chicago Capital Management sold 830,935 Esperion Therapeutics shares in Q3 2026, an estimated $2.61M.
  • Chicago Capital Management first reported a position in Esperion Therapeutics in Q2 2026 and held it in 1 quarter.
  • Chicago Capital Management's Esperion Therapeutics position peaked at $2.61M in Q2 2026.
  • 2 funds tracked by Wall St. Rank held Esperion Therapeutics as of Q3 2026.

Based on Chicago Capital Management's 13F filing for Q3 2026, filed 21 Oct 2026.